ADRA2A encodes the alpha-2A adrenergic receptor, a G protein-coupled receptor that binds catecholamines and activates Gi/o protein signaling pathways, leading to adenylyl cyclase inhibition and modulation of various physiological processes 1. The receptor is highly expressed in intestinal stem cells and serves as a target for microbial-derived tyramine from Enterococcus species, which suppresses stem cell proliferation and impairs epithelial regeneration, exacerbating colitis 2. ADRA2A plays a crucial role in cancer biology, where adrenergic stimulation activates YAP signaling to accelerate colorectal cancer growth 3. Paradoxically, ADRA2A agonists demonstrate potent anti-tumor effects in immunocompetent models by enhancing immune cell infiltration and reducing myeloid suppressor cells, requiring CD4+ and CD8+ T cells and macrophages for their therapeutic action 4. The receptor is also expressed in specialized intestinal BEST4/CA7+ cells, where norepinephrine-ADRA2A signaling blocks fluid secretion responses to bacterial toxins 5. Additionally, ADRA2A is found in novel bladder interstitial cells that may be involved in nerve conduction 6 and contributes to somatosensory-vagal-gastric reflexes activated by electroacupuncture 7. Genetic variants in ADRA2A are associated with ADHD pathogenesis 8 and influence dexmedetomidine pharmacodynamics in pediatric patients 1.